Observational studyBreast cancer research and treatment2023

Patient characteristics, treatment patterns, and outcomes of hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer patients prescribed cyclin-dependent kinase 4 and 6 inhibitors: large-scale data analysis using a Japanese claims database.

Masaaki Kawai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.